Wyeth’s marketing efforts admissible in Prempro case

Evidence of Wyeth’s marketing campaign for “off-label” Prempro uses was admissible in a product liability case brought by a woman who contracted breast cancer after taking the drug, a Pennsylvania appellate court has ruled. The plaintiff was diagnosed with breast cancer after taking Prempro, a hormone replacement therapy drug made by Wyeth. She filed a ...